We hope to be cured when we stay in hospital. But too often, we acquire new infections there. Such ‘healthcare-associated infections’ (HAI) are a growing problem worldwide, taking up an estimated 6% of global hospital budgets.
Pharma companies and their allies seek to exempt orphan drugs from state pricing limits
As more states create dedicated boards to cap the costs of medicines, some drugmakers and their allies are pushing back with a controversial tactic —
March 21, 2024